Objectives: To modify and validate in primary healthcare the Identification of Seniors at Risk (ISAR) screening questionnaire to identify older persons at increased risk of functional decline and to compare this strategy with risk stratification by age alone. Study Design and Setting: Prospective development (N=790) and validation cohorts (N=2,573) of community-dwelling persons aged ⩾70 years. Functional decline at 12 months was defined as an increase of at least one point on the modified Katzactivities of daily living index score compared with baseline or death. Results: Three items were independently associated with functional decline: age (odds ratio [OR]: 1.06 per year; 95% confidence interval [CI]: 1.02, 1.10), dependence in instrumental activities of daily living (OR: 2.17; 95% CI: 1.46, 3.22), and impaired memory (OR: 2.22; 95% CI: 1.41, 3.51). The area under the receiver operating characteristics curve (AUC) range of the ISAR-primary care model was 0.67-0.70, and 40.6% was identified at increased risk. Validation yielded an AUC range of 0.63-0.64. Age ⩾75 years alone yielded an AUC range of 0.56-0.57 and identified 55.4% at increased risk in the development cohort.
Introduction
The occurrence of new disabilities is often called functional decline. 1 This comprises a decline in activities of daily living (ADL) or instrumental activities of daily living (IADL).
Disabilities are associated with loss of independence, 2 need for hospital and nursing home care, 3 and mortality. 4 The annual incidence of (I)ADL disabilities ranged from 13% to 24% depending, among other things, on the applied definition. 5, 6 Functional decline places a high burden on social and economic resources in aging societies.
Meta-analyses of preventive interventions, such as complex interventions based
on comprehensive geriatric assessment, and multicomponent exercise programs in community-dwelling older persons demonstrate that functional decline can be postponed. [7] [8] [9] [10] Identifying older persons, who may benefit from a preventive intervention, at increased risk is therefore an important first step. 11 Over the last decades, considerable effort has been put into the identification of frail older persons in primary care. 12, 13 Different strategies exist for the identification of frail older persons. It can be based on self-assessment instruments for older persons, 14, 15 on the clinical judgment by the general practitioner (GP) 16 or on the routine healthcare data from the GPs' electronic medical record (EMR). 17 From the literature, it appears that exclusively focusing on complex care for frail elderly may not be efficient, because older persons with no or only mild disabilities who are at increased risk of functional deterioration are the most likely to benefit from preventive interventions. 11, 18 Extending preventive efforts toward somewhat younger people (70-75 years.) and a less frail (''prefrail'') population is therefore believed to increase the yield of comprehensive geriatric assessments and tailored interventions. 7, 10, 11, 19 To identify older persons at increased risk of functional decline a self-reporting, generic, easy-to-apply, and validated instrument is needed. Several other well-known instruments have the ability to predict functional decline over time, such as the Sherbrooke Postal Questionnaire, 20 Vulnerable Elders Survey, 21 the Groningen Frailty Index, 6 Tilburg Frailty Indicator, 14 and the Survey of Health, Ageing and Retirement in Europe-operationalized frailty phenotype. 22 However, some screening tools require external validation in a larger population 6, 20 or in a primary care setting. 6, 20, 21 The Identification of Seniors at Risk (ISAR) questionnaire is a self-report screening instrument that was validated to identify older persons at increased risk of functional decline who visit the emergency department (ED). 23 The ISAR is short and easy to administer and can be completed by patients or informal caregivers. Because the original ISAR contains risk factors that are associated with functional decline in community-dwelling older persons, 3, 24 we hypothesized that the ISAR could also be usable in a primary healthcare setting.
In some European countries, it is policy in primary healthcare to conduct annual multidimensional assessments to all persons aged ⩾75 years. 25 Selection by age is frequently used as a starting point for preventive interventions. 10 We hypothesized that the identification of older persons at increased risk of functional decline by a simple discriminative screening instrument is more efficient than based on age alone.
The aims of this study were therefore to (1) assess the predictive performance of the original ISAR questionnaire to detect older persons at increased risk of functional decline and further improve or modify the instrument where possible, (2) test a modified ISAR questionnaire in a validation cohort, and (3) compare the performance of the modified ISAR with risk stratification by age alone.
Methods

Design and setting of development and external validation cohorts
A prospective cohort study was conducted in seven general practices in the Netherlands. These practices had a mixed population in terms of sex, age, and socioeconomic status (SES) (Supplementary Table 1 ). Measurements of the development cohort began in October 2008, and the cohort was monitored for 12 months.
The modified ISAR was externally validated in another prospective cohort in 10 general practices in a north-western region of the Netherlands. Measurements of the external validation cohort began in December 2010, and the cohort was monitored for 12 months.
Participants in development and external validation cohorts
All community-dwelling persons aged ⩾70 years, registered in one of the participating general practices, were retrieved from the EMRs by their GP. Persons were excluded if they were terminally ill, were demented, did not understand Dutch, and planned to move or spend a long time abroad. Eligible persons received a letter from their GP with information about the study, along with a written informed consent form, a self-report questionnaire, and a prepaid envelope. They were invited to fill out the questionnaire themselves, and if they needed help, an informal caregiver was allowed to assist (this assistance was noted on the questionnaire). All participants were asked to provide written informed consent for data collection and participation in the study after receipt of the study information. Those persons unwilling to participate were asked to select one of three prestructured reasons on a reply card: too ill, not interested, or lack of time. They could also add their own comment. A postal reminder was sent after 3 weeks if no response was received. After 6 weeks, two attempts by phone were made to contact those who had failed to respond. The study was approved by the Medical Ethics Committee of the Academic Medical Center, University of Amsterdam (protocol ID MEC10/182).
Measures in development and external validation cohorts
In the development and external validation cohorts, baseline measures consisted of participant characteristics, original ISAR items, 23 modified Katz-ADL index score, 26 and other potential predictors of functional decline. Baseline measures are described in detail elsewhere. 27 A similar set of measures was obtained 6 and 12 months after baseline assessments.
Original and modified ISAR
The original ISAR questionnaire consists of six dichotomous self-rated questions on premorbid need of assistance, increased need of assistance, recent hospitalizations, impaired memory, visual impairment, and polypharmacy. 23, 28 Range of scores varied from 0 to 6 points. 23 At a cut-off of two points, the overall area under the curve (AUC) of the ISAR was 0.71 (95% confidence interval [CI]: 0.68, 0.74), and the sensitivity and specificity were 72% and 58% respectively. 23 A score of ⩾2 indicated that the patient was at increased risk of functional decline during the 6 months after the index ED visit.
We modified the ISAR item ''premorbid need of assistance'' into ''existing IADL dependence'' and the item ''increased need of assistance'' into ''existing ADL dependence,'' because we wanted to specify the questions for a community-dwelling population and ADL and IADL dependence are known risk factors for functional decline in a community-dwelling population. 21 The exact wording of the original ISAR and modified items were ''Before the illness or injury that brought you to the emergency, did you need someone to help you on a regular basis?'' (ISAR item) into ''Did you need assistance on a regular basis in the last month (e.g. preparing meals, shopping, housekeeping)?'' (modified question) and ''Since the illness or injury that brought you to the emergency, have you needed more help than usual to take care of yourself?'' (ISAR item) into ''Did you need assistance to take care of yourself in the last 24 hours (e.g. bathing, dressing, toileting)?'' (modified question).
The ISAR questions were translated based on forward translation similar to the translation of the ISAR-HP. 29 The translated questions were tested in a pilot study of two general practitioners, two registered nurses, and 20 participants.
Potential predictors of functional decline
Other potential predictors of functional decline are age, sex, ethnicity, level of education, SES, marital status, living situation, hearing impairment, unintentional weight loss, depression, falls, multimorbidity, ED visits, limitations in social activities, and self-rated health. 3, 24, [30] [31] [32] [33] These predictors were based on the literature and specified by experienced geriatricians and GPs (see Supplementary Table 2 ).
Outcome definition
Functional decline was defined as at least a one-point decline on the modified Katz-ADL index score at the 12-month follow-up compared with the baseline score. 26 Death was regarded as the most extreme manifestation of functional decline. On the basis of previous research 7 in which the smallest meaningful difference equated to half a point improvement on a 20-point scale, we determined the outcome of functional decline on at least one-point decline on the modified Katz-ADL (15-point scale) index to ensure that the decline would exceed the smallest meaningful difference.
Nonrespondent analysis in development cohort
To explore whether nonrespondents were more often functionally and/or cognitively impaired, a sample of randomly selected nonrespondents and a sample of randomly selected participants were invited to participate in a single home visit conducted by a trained research nurse. Nonrespondents who participated in this home visit gave written informed consent before the interview took place. During the home visit, the same baseline assessments were performed, along with the Mini-Mental State Examination (MMSE). 34 
Statistical analysis
For data analysis, the Statistical Package for Social Sciences (SPSS) version 19.0 and R version 2.13.1 (Hmisc package) was used.
In both the development and the validation cohorts, missing data were multiply imputed using participant characteristics, all potential predictors of functional decline, and the functional outcome. 35 Five imputation data sets were used. Table 1 lists where missing values occurred before imputation.
In the development cohort, discrimination of the original ISAR scale was estimated using the AUC of the receiver operating characteristics (ROC) curve. Next, we sought to improve the original ISAR by adding and/or removing variables associated with functional decline developing a new model, the ISAR-Primary Care (ISAR-PC). We developed the new model for the outcome functional decline or death.
Any potential predictor that was univariably associated with functional decline (P<0.20) was entered as a candidate in a multivariable logistic regression analysis.
Nineteen predictors met with this criterion. There were collinearities among the variables ADL dependence, IADL dependence, and limitations in social activities. As all participants with ADL dependence or limitations in social activities also had IADL dependence, the latter was considered more comprehensive and was kept in the remaining list of 18 potential predictors.
Two different selection strategies were used: Model A comprised the original ISAR items and known clinical predictors related to functional decline (hearing impairment, unintentional weight loss, falls, and depressive symptoms). These predictors were all dichotomous and easy to answer in self-reported questionnaires.
Model B comprised all 18 potential predictors, including demographic characteristics.
In both models, we used logistic regression with a manual stepwise backward elimination (p<0.05).
To avoid overfitting, the regression coefficients of the pooled prediction rule were shrunken using a heuristic shrinkage factor, based on the degrees of freedom from the model with all 18 potential predictors. 36 The heuristic shrinkage factor was estimated for each of the five imputation sets and averaged.
After recalibrating the intercept, the predictive performance of the two new models was first assessed in the development cohort. In each imputation set, the predicted probabilities of functional decline were compared with the observed frequencies to assess the discrimination and calibration. The discrimination was estimated using the AUC of the ROC curve. The calibration was assessed using a calibration plot. The calibration line was described via a logistic regression model with the observed outcome regressed on the prediction rule. [37] [38] [39] Based on its discrimination, calibration, easy applicability, and parsimony, the final model, ISAR-PC was selected. The ISARPC was then translated into a scorecard using the formula of Sullivan. 40 The final prediction rule from the development cohort was applied to the validation cohort. The AUC of the ROC curve was calculated for each imputation set, and calibration was tested using the calibration plot.
As sensitivity analyses, we repeated all analyses for the outcome functional decline only excluding deceased patients.
Model based on age only
To benchmark the newly developed ISAR-PC prediction rule, we compared it with a prediction rule based on age groups only. In both the development and validation cohorts, a logistic regression analysis based on age groups only (cut-off 75.0 years, based on the definition currently applied by Dutch healthcare insurance companies) was performed to identify older persons at increased risk of functional decline and its discrimination was assessed.
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Figure 1. Flowchart of development cohort and validation cohort
Results
Study population
The development cohort comprised 1,113 persons. Figure 1 shows reasons for exclusion and nonresponse. In total, 790 (76.3%) participants returned the baseline questionnaire and were included in the study. At baseline, the median age was 75.0 years, and 44.1% had one or more (I)ADL disabilities (Table 1) . Participants who were lost to follow-up at 12 months were more dependent in ADL and IADL and had more comorbidities and risk factors for functional decline at baseline (Supplementary Table   3 ).
The validation cohort comprised 4,040 persons. In total, 2,573 (69.1%) participants returned the baseline questionnaire and were included in the study. At baseline, the median age was 76.6 years, and 49.7% had one or more (I) ADL
disabilities (Table 1) .
Nonrespondents
In the developmental cohort, 7.9% (82 of 1,035) of the eligible persons were nonrespondents, aged 76.0 years. A random sample of 32 (39.0%) nonrespondents was willing to participate in a nonresponse sub-study that was initiated in conjunction with their own GP. Nonrespondents more often had ADL dependency, cognitive impairment, and lower SES compared with a random sample of 71 respondents (Table 2) . 
Outcomes after 12 months
In the developmental cohort, 31 Table 3 ). The AUC of this model ranged from 0.67 to 0.70 (Table 4 ) and calibration was good (Figure 2a ).
Including all potential predictors ( Table 3 , Model B) resulted in similar discriminative properties but was less feasible because it contained more items, including the item ethnicity, which is less applicable in a self-report questionnaire. Excluding deceased participants gave consistent results (data not shown).
After shrinkage of the regression coefficients by a factor 0.756, the intercept was recalculated, resulting in a prediction model with the following prediction rule for risk of functional decline:
P=exp a/(1+exp a) a=(-4.533+0.584*IADL dependence+0.604 * memory problems + 0.045*age)
The ISAR-PC comprised two of six original ISAR items (IADL dependence and impaired memory), and age was added. In the scorecard, age was turned into three categories for ease of use: 70-74, 75-84, and ⩾85 (Supplementary Table 4 ). The ISAR-PC classified 40 .6% of the population as being at increased risk of functional decline (Table 4) .
Within this group, 29.3% of the persons had a positive ISAR-PC score based on their age alone.
External validation of the ISAR-PC
In the five imputation sets of the validation cohort, the AUC of the ISAR-PC ranged from 0.63 to 0.64. Calibration slopes ranged from 0.92 to 0.99 and intercepts from 0.02 to 0.10. In all five sets, the joint hypothesis intercept=0 and slope=1 could not be rejected (range P-values: 0.09-0.78) indicating good calibration in all imputations sets ( Figure 2b ). 
Figure 2a
Selection by age
Selection by persons aged ⩾75 years resulted in an AUC that ranged from 0.56 to 0.59 in the development cohort and from 0.56 to 0.57 in the validation cohort. In the development cohort, at a cut-off of 75 years, 55.4% of the participants were classified as at increased risk of functional decline (Table 4 ). 
Discussion
In this prospective cohort study, we modified and validated the original ISAR screening questionnaire to an instrument to identify older persons at increased risk of functional decline in primary healthcare. The ISAR-PC comprises three variables predictive of functional decline: IADL dependence, self-reported memory complaints, and age. The ISAR-PC appeared to have moderate discrimination and was well calibrated. The ISAR-PC is quick and easy to apply and may serve as an efficient first step in a two-step approach targeting community-dwelling elderly at risk of functional decline. AUC=area under the receiver operating characteristics curve; ISAR=identification of seniors at risk; NPV=negative predictive value; PPV=positive predictive value. a Range in imputation set 1-5. b Cut-off of two points was used for both original ISAR and ISAR-PC.
In a population aged <85 years, the ISAR-PC is a more efficient strategy to identify persons at increased risk of functional decline than selection based on age alone. The higher specificity of the ISAR-PC results in less ''false positives''; healthy older persons who are falsely identified as being at increased risk.
Some difference exists between ISAR and ISAR-PC. The ISAR-PC comprises two of six original ISAR items (IADL dependence and impaired memory). Age was also a strong predictor in the original ISAR but was less applicable in the ED setting. ISAR items visual impairment and polypharmacy were only strong predictors in univariable analyses developing ISAR-PC. The separate variables associated with functional decline in our study also appeared to be strong predictors of functional decline in several other studies: age, 21,32,41 IADL, 21, 32, 41 and impaired memory. 41 This also supports the appropriateness of the individual items included in the ISAR-PC.
The ISAR-PC demonstrated a moderate discrimination in both the development and the external validation cohorts. The discriminative ability of several screening instruments to identify older persons at increased risk of functional decline ranges from 0.70 to 0.80. 6, 14, 21 Considering the heterogeneous group of community-dwelling older persons, the relatively long time frame in which decline takes place, and the reversible character of functional decline, it might be difficult to further increase the AUC. Similar results were described for frailty models predicting mortality. 6, 14, 42 However, widely used prediction models do not always have a high discriminative ability. 43 Their use is weighted against the relevance of outcomes, their face validity, and the available alternatives. As the differences between prediction models become smaller, more emphasis may be put on the feasibility of the screening instrument. 43 In terms of feasibility, the ISAR-PC is a simple and short survey that can be administered as a postal questionnaire in <3 minutes by a participant or his informal caregiver. It does not require any knowledge of medical diagnosis. However, because it is a prognostic tool that predicts future functional decline, GPs and registered nurses need training to comprehend its test characteristics and embed it in their clinical decision making.
In the coming years, both government and healthcare insurance companies will stimulate GPs to deliver systematic integrated care for all older people within their practice population. Therefore, in this study, we chose to invite participants to fill out the ISAR-PC on behalf of their GP. In the development cohort (N=1,035), the initial response on the invitation letter was generally high (N=635, 61.4%) and rose even further after one postal reminder and one telephone call (N=790, 76.3%) if they had still not responded. In regular practice, older persons will be aware that their GP invites them for a ''check-up'' to find out whether they have problems or are in need of additional care. Therefore, we expect the implementation rate of the ISAR-PC screening tool to be acceptably high, also outside the current study setting. Within this setting, extra questions were asked, because we wanted to develop and validate a prediction model; but in the implementation phase, only the ISAR-PC items will remain in the first selection step, lowering a possible threshold to respond. Nevertheless, efforts to send reminders or call nonrespondents might still be necessary.
Finally, both in research and in regular care, nonrespondents represent a broad range from very fit to very frail persons. Although the nonresponse sub-study did not reveal large absolute differences, it did show that nonrespondents have more ADL disabilities and a lower MMSE score at baseline. Within our data, the main reasons for nonresponse were no health problems (n=208, 18.1%), too ill (n=128, 11.1%), not interested (n=174, 15.1%), unknown reason (n=206, 17.9%), or no response at all (n=435, 37.8%; Figure 1 ). This also illustrates the mixture of healthy and frail persons in the nonresponse group. Therefore, nonrespondents should be closely monitored when starting up a comprehensive intervention strategy to prevent functional decline.
Limitations
Our study had some limitations.
First, 18.5% of the participants in the development cohort and 19.0% of the participants in the validation cohort had no follow-up at 12 months. This may have biased the results, as loss to follow-up was associated with increased levels of (I)ADL dependence at baseline. Selective attrition is a common problem in studies involving elderly participants. 44 As we wanted to develop a screening tool for the complete elderly population, we chose to impute missing data. 35 Second, the original ISAR item ''increased need of assistance'' was changed in ''ADL dependence in the last 24 hours.'' This time frame might have resulted in underreporting of ADL dependence. Nevertheless, the consequences of this time frame are probably small because collinearity existed between ADL and IADL dependence.
Third, the ISAR questions were translated based on forward translation only. Fourth, we were not able to compare the performance of ISAR-PC among older persons with and without cognitive impairment. Prior to the start of the study, patients with a diagnosis of dementia were excluded by their own GP. The validity of a dementia diagnosis by a Dutch GP was shown to be very high, yielding specificity and positive predictive values of almost 1.0% and 100%. 45 Therefore, we did not render it necessary to use additional criteria to further improve the validity of this procedure.
Conclusion
The ISAR-PC is a sensitive, quick, and easy to apply method to identify persons at increased risk of functional decline and may serve as an efficient first step in a comprehensive diagnosis and intervention strategy. Randomized clinical studies are needed to assess whether this way of prioritizing healthcare efforts is beneficial for patient-centered outcomes, such as functionality or health-related quality of life.
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